Michael Freeman
Stock Analyst at Raymond James
(0.82)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
WVE WAVE Life Sciences | Assumes: Outperform | 14 | 8.11 | 72.63% | 1 | Jun 11, 2025 | |
TECX Tectonic Therapeutic | Reinstates: Outperform | 76 | 22.01 | 245.3% | 1 | Jun 11, 2025 | |
DYN Dyne Therapeutics | Assumes: Outperform | 37 | 11.23 | 229.47% | 1 | Jun 11, 2025 | |
IRON Disc Medicine | Reinstates: Strong Buy | 89 | 58.61 | 51.85% | 1 | Jun 11, 2025 | |
RNA Avidity Biosciences | Initiates Coverage On: Strong Buy | 65 | 45.74 | 42.11% | 1 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | 8 | 6.67 | 19.94% | 1 | Jul 10, 2024 |